Singh Roshani Narayan, Mete Vanessa, van Driessche Willy, Omran Heymut, Weber Wolf-Michael, Grosse-Onnebrink Jörg
Department of General Pediatrics, University Hospital Muenster, Albert-Schweitzer-Campus 1, 48149 Muenster, Germany.
EP Design, Tervuursesteenweg 154, B-3060 Bertem, Belgium.
Int J Mol Sci. 2025 Aug 6;26(15):7618. doi: 10.3390/ijms26157618.
Cystic fibrosis (CF), the most common hereditary lung disease in Caucasians, is caused by dysfunction of the cystic fibrosis transmembrane conductance regulator (CFTR). We evaluated CFTR function using a newly developed Ussing chamber system, the Multi Trans Epithelial Current Clamp (MTECC), in an in vitro model of human airway epithelia. Air-liquid interface (ALI) cultures were established from nasal brushings of healthy controls (HC) and CF patients with biallelic CFTR variants. ALI layer thickness was similar between groups (HC: 62 ± 13 µm; CF: 55 ± 9 µm). Immunofluorescence showed apical CFTR expression in HC, but reduced or absent signal in CF cultures. MTECC enabled continuous measurement of transepithelial resistance (Rt), potential difference (PD), and conductance (G). G was significantly reduced in CF cultures compared to HC (0.825 ± 0.024 vs. -0.054 ± 0.016 mS/cm), indicating impaired cAMP-inducible ion transport by CFTR. Treatment of CF cultures with elexacaftor, tezacaftor, and ivacaftor (Trikafta) increased G, reflecting partial restoration of CFTR function. These findings demonstrate the utility of MTECC in detecting functional differences in CFTR activity and support its use as a platform for evaluating CFTR-modulating therapies. Our model may contribute to the development of personalized treatment strategies for CF patients.
囊性纤维化(CF)是白种人中最常见的遗传性肺部疾病,由囊性纤维化跨膜传导调节因子(CFTR)功能障碍引起。我们在人呼吸道上皮细胞的体外模型中,使用新开发的尤斯灌流小室系统——多跨上皮电流钳(MTECC),评估了CFTR的功能。从健康对照(HC)和具有双等位基因CFTR变异的CF患者的鼻拭子中建立气液界面(ALI)培养物。两组之间的ALI层厚度相似(HC:62±13μm;CF:55±9μm)。免疫荧光显示HC中CFTR在顶端表达,但CF培养物中的信号减弱或缺失。MTECC能够连续测量跨上皮电阻(Rt)、电位差(PD)和电导(G)。与HC相比,CF培养物中的G显著降低(0.825±0.024对-0.054±0.016 mS/cm),表明CFTR介导的cAMP诱导的离子转运受损。用依列卡福、替扎卡福和依伐卡托(三联疗法)治疗CF培养物可增加G,反映出CFTR功能的部分恢复。这些发现证明了MTECC在检测CFTR活性功能差异方面的实用性,并支持将其用作评估CFTR调节疗法的平台。我们的模型可能有助于为CF患者制定个性化治疗策略。